| PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges MA Khan, VK Jain, M Rizwanullah, J Ahmad, K Jain Drug discovery today 24 (11), 2181-2191, 2019 | 241 | 2019 |
| Nanotechnology-based inhalation treatments for lung cancer: state of the art J Ahmad, S Akhter, M Rizwanullah, S Amin, M Rahman, MZ Ahmad, ... Nanotechnology, science and applications, 55-66, 2015 | 210 | 2015 |
| Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics MH Akhter, M Rizwanullah, J Ahmad, MJ Ahsan, MA Mujtaba, S Amin Artificial cells, nanomedicine, and biotechnology 46 (5), 873-884, 2018 | 145 | 2018 |
| Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and … K Soni, MD Rizwanullah, K Kohli Artificial cells, nanomedicine, and biotechnology 46 (sup1), 15-31, 2018 | 122 | 2018 |
| Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment Z Saifi, M Rizwanullah, SR Mir, S Amin Journal of Drug Delivery Science and Technology 57, 101634, 2020 | 117 | 2020 |
| Nanostructured lipid carriers: a novel platform for chemotherapeutics M Rizwanullah, J Ahmad, S Amin Current drug delivery 13 (1), 4-26, 2016 | 110 | 2016 |
| Phytochemical based nanomedicines against cancer: current status and future prospects M Rizwanullah, S Amin, SR Mir, KU Fakhri, MMA Rizvi Journal of drug targeting 26 (9), 731-752, 2018 | 105 | 2018 |
| Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers M Rizwanullah, S Amin, J Ahmad Journal of drug targeting 25 (1), 58-74, 2017 | 99 | 2017 |
| Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments MS Shahab, M Rizwanullah, S Alshehri, SS Imam International journal of biological macromolecules 163, 2392-2404, 2020 | 91 | 2020 |
| Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy MZ Ahmad, M Rizwanullah, J Ahmad, MY Alasmary, MH Akhter, ... International Journal of Polymeric Materials and Polymeric Biomaterials 71 …, 2022 | 90 | 2022 |
| Bile salt stabilized vesicles (bilosomes): a novel nano-pharmaceutical design for oral delivery of proteins and peptides J Ahmad, M Singhal, S Amin, M Rizwanullah, S Akhter, M Amjad Kamal, ... Current pharmaceutical design 23 (11), 1575-1588, 2017 | 87 | 2017 |
| Progress of cancer nanotechnology as diagnostics, therapeutics, and theranostics nanomedicine: preclinical promise and translational challenges S Alshehri, SS Imam, M Rizwanullah, S Akhter, W Mahdi, M Kazi, ... Pharmaceutics 13 (1), 24, 2020 | 82 | 2020 |
| Paclitaxel-loaded nanolipidic carriers with improved oral bioavailability and anticancer activity against human liver carcinoma Harshita, MA Barkat, M Rizwanullah, S Beg, FH Pottoo, S Siddiqui, ... AAPS PharmSciTech 20 (2), 87, 2019 | 79 | 2019 |
| Nanotechnology based theranostic approaches in Alzheimer's disease management: current status and future perspective J Ahmad, S Akhter, M Rizwanullah, M Ahmed Khan, L Pigeon, R T. Addo, ... Current Alzheimer Research 14 (11), 1164-1181, 2017 | 75 | 2017 |
| Cilnidipine loaded transfersomes for transdermal application: formulation optimization, in-vitro and in-vivo study K Khatoon, MD Rizwanullah, S Amin, SR Mir, S Akhter Journal of Drug Delivery Science and Technology 54, 101303, 2019 | 63 | 2019 |
| Polymer-lipid hybrid nanoparticles: A next-generation nanocarrier for targeted treatment of solid tumors M Rizwanullah, M Alam, Harshita, SR Mir, MMA Rizvi, S Amin Current Pharmaceutical Design 26 (11), 1206-1215, 2020 | 57 | 2020 |
| Chitosan coated luteolin nanostructured lipid carriers: optimization, in vitro-ex vivo assessments and cytotoxicity study in breast cancer cells SJ Gilani, M Bin-Jumah, M Rizwanullah, SS Imam, K Imtiyaz, S Alshehri, ... Coatings 11 (2), 158, 2021 | 52 | 2021 |
| Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application M Rizwanullah, MZ Ahmad, A Garg, J Ahmad Biochimica et Biophysica Acta (BBA)-General Subjects 1865 (9), 129936, 2021 | 51 | 2021 |
| Recent advancement in chitosan-based nanoparticles for improved oral bioavailability and bioactivity of phytochemicals: Challenges and perspectives SS Imam, S Alshehri, MM Ghoneim, A Zafar, OA Alsaidan, NK Alruwaili, ... Polymers 13 (22), 4036, 2021 | 47 | 2021 |
| Nanomedicines in diagnosis and treatment of cancer: an update N Haider, S Fatima, M Taha, M Rizwanullah, J Firdous, R Ahmad, ... Current Pharmaceutical Design 26 (11), 1216-1231, 2020 | 46 | 2020 |
Javed AhmadAssociate Professor, College of Pharmacy, Najran University, KSABestätigte E-Mail-Adresse bei nu.edu.sa
